Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Opiant gets Canadian clearance for overdose spray

Wednesday, October 5, 2016 8:21
% of readers think this story is Fact. Add your two cents.

Opiant Pharmaceuticals Inc (OTCQB:OPNT) has received regulatory clearance in Canada for its Narcan opioid overdose nasal spray.

“This is a life-saving move by Canada’s health minister who has declared a significant public health emergency,” said Roger Crystal, Opiant’s chief executive.

“We are pleased that our commercial partner Adapt cooperated with Health Canada to help expedite the approval,” he added.

Kevin Pollack, Opiant’s chief financial officer, added: “From a financial perspective, we expect to receive a milestone payment triggered by Health Canada’s approval.”

Opiant agreed a licensing deal with a subsidiary of Adapt in 2014.

Through this, Opiant can receive total potential milestone payments of more than US$55mln plus up to double-digit percentage royalties on net sales.

Narcan was launched in the US in February by Adapt and is the only naloxone nasal spray for emergency treatment approved by the US FDA for known or suspected drug overdoses.

Shares in California-based Opiant rose 2% to US$8.25.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.